These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36457504)

  • 1. Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer
    Li J; Zhou F; Shang L; Liu N; Liu Y; Zhang M; Wang S; Yang S
    Front Oncol; 2022; 12():961653. PubMed ID: 36457504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
    Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
    Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
    Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
    Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YYFZBJS ameliorates colorectal cancer progression in Apc
    Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
    Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YYFZBJS inhibits colorectal tumorigenesis by enhancing Tregs-induced immunosuppression through HIF-1α mediated hypoxia in vivo and in vitro.
    Zhang Y; Chai N; Wei Z; Li Z; Zhang L; Zhang M; Ren J; Xu R; Pang X; Zhang B; Tang Q; Sui H
    Phytomedicine; 2022 Apr; 98():153917. PubMed ID: 35093671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Network Pharmacology and Experimental Validation to Study the Action and Mechanism of Water extract of Asparagus Against Colorectal Cancer.
    Liang H; Li Y; Wang F; Zhao J; Yang X; Wu D; Zhang C; Liu Y; Huang J; Su M; He Z; Liu Y; Wang J; Tang D
    Front Pharmacol; 2022; 13():862966. PubMed ID: 35774597
    [No Abstract]   [Full Text] [Related]  

  • 9. Network pharmacology and experimental verification-based strategy to explore the underlying mechanism of Liu Jun An Wei formula in the treatment of gastrointestinal reactions caused by chemotherapy for colorectal cancer.
    Li G; Liu L; Yin Y; Wang M; Wang L; Dou J; Wu H; Yang Y; He B
    Front Pharmacol; 2022; 13():999115. PubMed ID: 36204230
    [No Abstract]   [Full Text] [Related]  

  • 10. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-
    Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
    Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting colorectal cancer with Herba Patriniae and Coix seed: Network pharmacology, molecular docking, and
    Wang CL; Yang BW; Wang XY; Chen X; Li WD; Zhai HY; Wu Y; Cui MY; Wu JH; Meng QH; Zhang N
    World J Gastrointest Oncol; 2024 Aug; 16(8):3539-3558. PubMed ID: 39171161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YYFZBJS inhibits colorectal tumorigenesis by remodeling gut microbiota and influence on M2 macrophage polarization
    Chai N; Xiong Y; Zhang Y; Cheng Y; Shi W; Yao Y; Sui H; Zhu H
    Am J Cancer Res; 2021; 11(11):5338-5357. PubMed ID: 34873464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
    Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
    BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of
    Zhang W; Sang S; Peng C; Li GQ; Ou L; Feng Z; Zou Y; Yuan Y; Yao M
    Front Oncol; 2022; 12():807718. PubMed ID: 35646655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology.
    Shang W; Zhang J; Song H; Zhu S; Zhang A; Hua Y; Han S; Fu Y
    Drug Des Devel Ther; 2021; 15():2907-2919. PubMed ID: 34262258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation.
    Ma S; Guo X; Han R; Meng Q; Zhang Y; Quan W; Miao S; Yang Z; Shi X; Wang S
    Front Pharmacol; 2024; 15():1355644. PubMed ID: 38384287
    [No Abstract]   [Full Text] [Related]  

  • 17. Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer.
    Wang Z; Cui Q; Shi L; Zhang M; Song P; Duan D; Guo W
    Recent Pat Anticancer Drug Discov; 2022; 17(3):297-311. PubMed ID: 34951580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment.
    Wang K; Miao X; Kong F; Huang S; Mo J; Jin C; Zheng Y
    Drug Des Devel Ther; 2021; 15():3749-3764. PubMed ID: 34511884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
    Gao J; Yang S; Xie G; Pan J; Zhu F
    Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effects of OSW-1 on glioma cells via regulation of the PI3K/AKT signal pathway: A network pharmacology approach and experimental validation
    Zhan Z; Liu Z; Zhang C; Gao H; Lai J; Chen Y; Huang H
    Front Pharmacol; 2022; 13():967141. PubMed ID: 36133816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.